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Abstract
Biofilms are surface-adhered bacterial communities encased in an extracellular matrix composed of DNA, bacterial
polysaccharides and proteins, which are up to 1000-fold more antibiotic resistant than planktonic cultures. To date,
extracellular DNA has been shown to function as a structural support to maintain Pseudomonas aeruginosa biofilm
architecture. Here we show that DNA is a multifaceted component of P. aeruginosa biofilms. At physiologically relevant
concentrations, extracellular DNA has antimicrobial activity, causing cell lysis by chelating cations that stabilize
lipopolysaccharide (LPS) and the outer membrane (OM). DNA-mediated killing occurred within minutes, as a result of
perturbation of both the outer and inner membrane (IM) and the release of cytoplasmic contents, including genomic DNA.
Sub-inhibitory concentrations of DNA created a cation-limited environment that resulted in induction of the PhoPQ- and
PmrAB-regulated cationic antimicrobial peptide resistance operon PA3552–PA3559 in P. aeruginosa. Furthermore, DNA-
induced expression of this operon resulted in up to 2560-fold increased resistance to cationic antimicrobial peptides and
640-fold increased resistance to aminoglycosides, but had no effect on b-lactam and fluoroquinolone resistance. Thus, the
presence of extracellular DNA in the biofilm matrix contributes to cation gradients, genomic DNA release and inducible
antibiotic resistance. DNA-rich environments, including biofilms and other infection sites like the CF lung, are likely the in
vivo environments where extracellular pathogens such as P. aeruginosa encounter cation limitation.
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Introduction
Pseudomonas aeruginosa is an opportunistic pathogen capable of
causing both acute and chronic infections. It is the third-leading
cause of nosocomial infections and is the predominant pathogen
associated with morbidity and mortality of CF patients [1,2]. The
biofilm-forming ability of P. aeruginosa, and indeed other bacteria,
is thought to contribute to their ability to thrive in hostile host
environments and result in chronic infection [3,4].
Biofilms are multicellular surface-associated microbial commu-
nities encased in an extracellular matrix which display a
characteristic structure and increased resistance to antimicrobial
compounds and environmental stresses. P. aeruginosa biofilms are
up to 1000-fold more antibiotic tolerant than planktonic cells, to
single and combination antibiotics [5–7]. As acute CF exacerba-
tions caused by P. aeruginosa are often treated with combination
antibiotic therapy [8–10], the increased resistance of biofilms to
combination antibiotics is of direct clinical relevance.
Eighty five percent of P. aeruginosa strains isolated from the lungs
of CF patients with advanced stages of disease have a distinctive
mucoid colony morphology [11]. This mucoid phenotype is a
result of overproduction of the alginate exopolysaccharide (EPS)
[1,12]. Alginate production has been shown to inhibit phagocytic
killing of Pseudomonas, to protect from antibiotic exposure [13,14],
and is associated with poor prognosis for the infected patients
[15,16]. The direct observation of P. aeruginosa microcolonies
encased in an alginate matrix in microscopy studies of CF
bronchial samples [17], along with a large body of additional in
vitro and in vivo data [7,18–21] suggests that P. aeruginosa forms
biofilms in the lungs of CF patients.
The mechanisms of biofilm-associated antibiotic resistance are
distinct from the well studied intrinsic resistance mechanisms such as
drug efflux, drug inactivation, membrane permeability and target site
alterations. Although the basis of biofilm-associated antibiotic
resistance is not fully understood, it is likely that multiple mechanisms
operate simultaneously in biofilms to contribute to antibiotic
resistance. Cells in a biofilm may be protected from antibiotic
exposure due to the restricted penetration of antibiotics through the
biofilm matrix [19]. However, while the biofilm matrix may limit
diffusion initially for certain antibiotics such as b-lactams and
aminoglycosides [14,22], the penetration of fluoroquinolones occurs
immediately and without delay [23–25]. The rate of diffusion
through the matrix is presumably dependent on binding of the
antibiotic molecules to the EPS matrix. Once the matrix becomes
saturated, diffusion and antimicrobial activity of the drug will resume
[26]. It is the general consensus that reduced diffusion through the
biofilm matrix only provides a short-term protective effect and does
not play a significant role during long-term antibiotic exposure [26].
Other resistance mechanisms include the presence of subpop-
ulations of multidrug tolerant persister cells [27–29], drug
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unique resistance mechanisms specifically associated with biofilms
[31,32]. Despite the fact that biofilms are recognized as the
predominant mode of bacterial growth in nature and are
responsible for the majority of refractory bacterial infections
[19], little is known regarding the mechanisms of biofilm-specific
antibiotic resistance. Furthering our understanding of the
mechanisms underlying biofilm-associated antibiotic resistance
will significantly improve the treatment options available to
patients with chronic bacterial infections.
Signal transduction systems have been documented to be
involved in the regulation of biofilm formation in multiple
bacterial species including P. aeruginosa, S. aureus, E. coli and V.
fischeri [33–38]. These two component systems (TCS) are
comprised of an membrane-anchored histidine kinase sensor and
a cytoplasmic response regulator. After detecting specific environ-
mental signals, a signal transduction cascade is initiated that results
in phosphorylation of the response regulator, which activates or
represses the necessary target genes. A number of regulatory
systems that influence biofilm formation have been described.
These include, but are not limited to, the global virulence factor
regulator GacA, mutation of which results in a 10-fold decrease in
biofilm formation and failure to form microcolony structures [33].
Additionally, the hybrid sensor kinases, LadS and RetS appear to
work upstream of GacA to possibly control the switch to a biofilm
lifestyle [34,35]. Mutations in algR, a response regulator protein
required for synthesis of alginate, which is a major component of
the matrix of biofilms in the cystic fibrosis lung [1] results in a P.
aeruginosa strain that has decreased type IV pili-dependent motility
and biofilm formation [39]. The three-component system SadARS
which regulates the formation of mature microcolonies [40] and
PvrR, a response regulator involved in the switch from planktonic
to antibiotic-resistant biofilm cells in P. aeruginosa are additional
examples of regulators of biofilm formation [41].
During the course of an infection, one of the first lines of defense
encountered by colonizing bacteria is the production of cationic
antimicrobial peptides (CAPs) by a variety of host cells including
neutrophils, platelets and epithelia. CAPs are short, amphipathic
peptides that bind to and disrupt both the outer and cytoplasmic
membranes resulting in cell death. The broad-spectrum antimi-
crobial activity of CAPs against Gram-negative and Gram-positive
bacteria accounts for their role as an essential component of the
innate immune response of humans, animals and insects. Cationic
peptides, which have antimicrobial and immunomodulatory
activities, are being developed as a promising new class of
therapeutically relevant drugs [42].
In P. aeruginosa, resistance to CAPs is inducible by the PhoPQ
and PmrAB TCSs, both of which are activated independently in
response to limiting Mg
2+ [43–46]. Under conditions of limiting
magnesium, PhoP and PmrA bind to the promoter of the CAP
resistance operon PA3552–PA3559 (arnBCADTEF-ugd) and induce
its expression [45–47]. These genes encode an LPS modification
pathway required for the addition of aminoarabinose to lipid A,
which reduces the OM permeability to CAPs [48]. The PhoPQ
and PmrAB regulatory systems are well studied in planktonic
cultures and have been shown to induce modest resistance to
CAPs (8-fold) under low Mg
2+ conditions [45]. However, while the
PA3552–PA3559 operon has been reported to be expressed in
biofilms cultivated in flowcells, and is required for survival in
response to colistin treatment [49], little else is known regarding
these systems and the role they may play in biofilm-associated
antibiotic resistance.
The extracellular matrix of P. aeruginosa biofilms includes
extracellular DNA [50,51], multiple bacterial exopolysaccharides
and host proteins [4,52]. Extracellular DNA, which is a matrix
component of both Gram-positive and Gram-negative bacterial
biofilms [51,53], functions to maintain the 3D biofilm architecture
by acting as a cell-cell interconnecting compound [50]. Genomic
DNA has been shown to localize to the biofilm surface,
surrounding the mushroom-shaped microcolonies [51]. DNA in
the biofilm matrix is likely released by dead bacteria or immune
cells. It has been reported that prophage-mediated cell death is an
important mechanism in the differentiation and dispersal of
biofilms [54,55]. Additional sources of DNA in biofilms may
include the quorum sensing regulated release of DNA [51] and/or
DNA contained within outer membrane vesicles (OMV) that bleb
and are released from the OM of living P. aeruginosa cells [56,57].
Furthermore, while a specific mechanism of DNA release has not
been reported for P. aeruginosa it is possible that such a method may
exist, similar to the autolysin-mediated DNA release observed in
Staphylococcus epidermidis biofilms [53].
In this study we sought to examine if the presence of DNA in
biofilms may contribute to biofilm-specific antibiotic resistance.
Here we identify a novel cation chelating property of DNA, which
has several important consequences for biofilm physiology and
antibiotic resistance in biofilms.
Results
Extracellular DNA has antimicrobial activity
To study the role of the matrix component DNA on biofilm
formation and biofilm-associated antibiotic resistance, we first
examined the influence of extracellular DNA on P. aeruginosa
growth in rich and defined media, LB and BM2, respectively.
Addition of 0.5% (w/v) (5 mg/ml) or greater extracellular DNA to
LB or 1% (w/v) or greater DNA to BM2 media inhibited growth
of P. aeruginosa (Fig 1A and 1B). The kinetics of killing by
extracellular DNA was determined by measuring the loss of
luminescence from a chromosomally-tagged luminescent P.
aeruginosa strain, PAO1::p16Slux. DNA-mediated killing was fast,
Author Summary
Pseudomonas aeruginosa is an opportunistic pathogen,
which causes a variety of serious infections in immuno-
compromised patients and cystic fibrosis (CF) sufferers.
The biofilm-forming ability of P. aeruginosa is thought to
contribute to chronic P. aeruginosa infection of the CF
lung. Biofilms are dense communities of bacteria, encased
in an extracellular matrix, that are practically impossible to
eradicate using available antimicrobial therapies. Under-
standing the mechanisms by which biofilm bacteria
develop resistance to antibiotics is paramount to expand-
ing the treatment options available to patients with
chronic biofilm infections. In this study we have identified
a novel mechanism of biofilm-specific antibiotic resistance.
Extracellular DNA, a known component of biofilms, was
found to induce antibiotic resistance. This previously
unidentified function of DNA was due to its ability to
bind and sequester cations, including magnesium, from
the surrounding environment. This environmental cue was
then detected by P. aeruginosa leading to induction of
genes involved in modification of the cell surface
component, lipopolysaccharide (LPS), resulting in physical
alterations in the bacterial outer membrane (OM). These
results demonstrate a novel function for DNA in biofilms
and identify cation chelation by DNA as a previously
unrecognized mechanism, which can explain the increased
resistance of biofilms to antimicrobial agents.
DNA Induces Antibiotic Resistance
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upon exposure to 1.25% (w/v) DNA, or greater (Fig 1C). Killing
was dose-dependent, with faster killing observed as the DNA
concentration increased (Fig 1C). The rapid decrease in
luminescence corresponded with a loss of bacterial viability, as
determined by plating (Fig 1D).
One percent (w/v) extracellular DNA in LB also inhibited the
growth of Escherichia coli, Staphylococcus aureus and Burkholderia
cenocepacia (data not shown), suggesting that the antimicrobial
activity of DNA is not unique to P. aeruginosa.
Extracellular DNA induces cell death by membrane
perturbation and cell lysis
DNA is a highly anionic polymer due to the phosphates in the
deoxyribose backbone. This property, in combination with the
fast-killing observed in response to extracellular DNA led us to
hypothesize that addition of exogenous DNA resulted in the loss of
membrane integrity through cation chelation, in a manner similar
to that observed with the known cation chelator EDTA [58]. The
OM of P. aeruginosa contains a 20:1 ratio of Mg
2+:Ca
2+ cations
[59], which bind to and stabilize LPS in the outer leaflet of the
OM [58]. EDTA treatment of cells resulted in chelation and
removal of divalent cations from the OM, leading to disruption of
the OM [58]. To determine the effect of DNA on membrane
integrity, microscopic analysis in response to lethal concentrations
of DNA and relevant controls was performed.
Lipoproteins are lipid-modified proteins anchored in the outer
leaflet of the IM or the inner leaflet of the OM. P. aeruginosa cells
producing mCherry fluorescent membrane-anchored lipoproteins
(lipoChFP) that are localized to either the OM or IM [60,61] were
used as markers of OM and IM integrity. LipoChFP-labelled P.
aeruginosa cells showed dramatic membrane perturbations when
exposed to 2% (w/v) DNA, but showed uniform membrane
staining patterns in untreated cells (Fig 2A). The OM perturba-
tions in DNA-exposed cells included regions of patchy fluores-
cence and the release of OMVs, while the IM perturbations were
visualized simply as patchy and irregular regions of membrane
fluorescence (Fig 2A). EDTA, the known cation chelator caused
comparable IM and OM perturbations as those observed in cells
exposed to extracellular DNA. Propidium iodide (PI) stains
extracellular DNA and DNA in dead cells. PI staining was
Figure 1. Extracellular DNA inhibits planktonic growth by rapidly killing Pseudomonas aeruginosa. Growth of PAO1 in (A) LB or (B) BM2
media in cultures supplemented with % (w/v) extracellular salmon sperm DNA, as indicated. Growth (OD600) was measured every 20 minutes, over
20 h. (C) Overnight cultures of PAO1::p16slux were washed and 5610
7 cfu resuspended in sodium phosphate buffer (25 mM, pH 7.4). Resuspended
cells were treated with varying concentrations of salmon sperm DNA, as indicated, and luminescence was measured in cps (counts per second) over
time, as a measure of viability. Cells were also resuspended in buffer +0% (w/v) DNA as a negative control. Data is expressed as percentage survival
relative to the untreated control. For experiments 1A–C the mean of three replicate experiments is represented. The standard deviation, omitted for
clarity, was not greater than +/210% the mean. (D) The loss of viability of PAO1::p16Slux, following 2% (w/v) DNA treatment, was confirmed by
stamping of cultures at indicated time points post-treatment on LB agar. Cells resuspended in buffer in the absence of DNA remained viable. Two
replicate wells are shown for each condition.
doi:10.1371/journal.ppat.1000213.g001
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treatment was lethal (Fig 2B). PI staining also revealed the
presence of long strands of genomic DNA, presumably as a
consequence of the loss of membrane integrity, cell lysis and
release of cytoplasmic contents, including DNA (Fig 2B). The
DNA released by lysed cells formed a mesh-like coating
surrounding and connecting individual bacterial cells (Fig 2B).
Degradation of these strands by DNAse treatment of lysed cells
confirmed that these fibres were composed of DNA (Fig S1).
Pseudomonas specific semi-quantitative PCR (qPCR) was also
performed to confirm that the DNA released following DNA or
EDTA treated cells was in fact genomic DNA from P. aeruginosa
(Fig 2C). Buffer treated control cells showed intense green staining
with syto9 (indicating viability) and a lack of PI staining (indicating
no dead/dying cells or DNA release) (Fig S1).
DNA has cation chelating activity
The observation that DNA disrupted the integrity of the cell
envelope causing cell lysis suggested that DNA was acting as a
cation chelator. To confirm that DNA-mediated killing was a
result of cation chelation, excess Mg
2+,C a
2+,M n
2+, and Zn
2+
were added to P. aeruginosa cultures. The rapidity of DNA-induced
cell death ruled out the possibility that death, or lack of growth,
was simply due to cation starvation. Addition of excess cations to
planktonic cultures inhibited the fast-acting antimicrobial effects of
DNA (Fig 3A). Protection was measured in response to a range of
cation concentrations, where the highest concentration tested was
that which remained soluble in the presence of DNA (3.125–
25 mM). The concentration at which maximal protection was
obtained for each cation is represented in Fig 3A (25 mM Mg
2+;
6.25 mM Ca
2+; 6.25 Mn
2+; 3.125 mM Zn
2+). Kill curve assays
indicated that the addition of Mg
2+,C a
2+ or Mn
2+ provided
protection from DNA-induced lysis, however, the addition of Zn
2+
did not protect from DNA-mediated killing (Fig 3A). In a similar
manner, the addition of excess Mg
2+,C a
2+ and Mn
2+ restored
growth of P. aeruginosa in BM2 media. Only partial restoration of
growth was observed in the presence of Zn
2+ (Fig 3B). The
increased protection observed following addition of Mg
2+ and
Ca
2+ is likely due to their importance in membrane integrity where
they function to stabilize the OM by crosslinking adjacent LPS
molecules [58].
Cations play diverse physiologically important roles within a
cell; from detoxification of reactive oxygen species and co-factors
for enzymes to the stabilization of macromolecules within the cell
[62]. Since Mg
2+ limitation has been shown to be associated with
CAP resistance in P. aeruginosa [44,45,47], we sought to determine
if Mg
2+ chelation by DNA may account, at least in part, for the
increased antibiotic resistance observed in biofilms.
Figure 2. Extracellular DNA induces membrane perturbation, cell lysis, DNA release and death. (A) Membrane integrity was monitored
by visualizing DNA, EDTA or buffer treated P. aeruginosa producing mCherry fluorescent lipoproteins in either the IM or OM. The release of OMVs
(white arrow) and genomic DNA strands (grey arrow) into the extracellular milieu following cell lysis in response to DNA or EDTA treatment was
demonstrated by (B) PI staining and (C) semi-quantitative PCR which detects P. aeruginosa genomic DNA but not salmon sperm DNA. Cells were
treated with 2% (w/v) salmon sperm DNA, 2 mM EDTA, or buffer alone (negative control), pelleted and 1 ml of supernatent used as a template for
semi-quantitative PCR. PCR controls included 2% (w/v) salmon sperm DNA (primer specificity) and a negative and positive PCR control. The scale bar
equals 2.5 microns.
doi:10.1371/journal.ppat.1000213.g002
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PA3559 CAP resistance operon in planktonic cultures
In P. aeruginosa, the PhoPQ and PmrAB-controlled response to
magnesium limitation includes the induction of the PA3552 and its
neighbouring genes. The genes PA3552–PA3559 are co-regulated
under low Mg
2+ conditions and are thought to be organized as an
operon [45–47]. These genes encode an LPS modification
pathway required for the addition of aminoarabinose to lipid A,
which reduces the OM permeability to CAPs, thus conferring
resistance [48]. To determine if extracellular DNA imposes Mg
2+
limitation, we measured the gene expression of a chromosomally
encoded transcriptional lux (bioluminescence) fusion to PA3553,a s
a measure of the CAP resistance operon expression in planktonic
cultures. PA3553::lux expression was strongly induced (up to 10-
fold) by sub-inhibitory concentrations of low molecular weight
salmon sperm DNA (Fig 4A). Induction of the CAP resistance
operon was dose-dependent with increasing DNA concentrations
up to 0.5% (w/v) DNA, at which growth is inhibited (Fig 4A).
Addition of excess Mg
2+ (5 mM) to the growth medium completely
repressed the expression of PA3553 in cultures supplemented with
DNA, except at the highest DNA concentration tested (0.5% (w/
v)) (Fig 4B). A similar induction profile of PA3553::lux was observed
following exposure to high molecular weight P. aeruginosa genomic
DNA (not shown) or P. aeruginosa genomic DNA that was
mechanically sheared by sonication (Fig 4C). P. aeruginosa genomic
DNA inhibited growth at similar concentrations as salmon sperm
DNA. Thus, the ability of extracellular DNA to chelate
magnesium is independent of origin and molecular weight,
indicating that chelation is a general property of this negatively
charged polymer. To ensure that induction of PA3553 expression
was specific to the ability of DNA to chelate cations, DNAse
treated DNA was assessed for its ability to induce PA3553 gene
expression (Fig 4D). DNAse treated DNA failed to induce PA3553
gene expression. However the addition of DNAse buffer to cells in
our buffer control experiment also abolished induction of PA3553.
This is due to the addition of excess Mg
2+ ions as part of the
DNAse buffer, which is required for DNAse activity. Thus, it is
impossible to determine conclusively if DNAse treatment of DNA
abolished PA3553 gene expression.
Expression of the CAP resistance operon PA3552–PA3559
is induced in biofilms in response to extracellular DNA
To determine the influence of extracellular DNA on PA3553
gene expression in biofilms, DNA-enriched biofilms were
cultivated on the surface of polystyrene pegs. Consistent with
previous reports that DNA is a component of biofilms [50,51], we
observed DNA in 24 h old peg-adhered biofilms (Fig 5A and 5B).
Double staining of P. aeruginosa with syto9 (stains viable cells green)
and the extracellular DNA stain DDAO (red) [51] was used to
visualize DNA as a loose lattice in biofilms formed on polystyrene
pegs after 24 h (Fig 5A). DNA was also visualized (PI stained) as a
mesh-like DNA matrix in 1 day-old peg-adhered biofilm
monolayers (Fig 5B), which resembled the thread-like projections
of genomic DNA observed in DNA or EDTA-lysed cells (Fig 2B).
These localization patterns of extracellular DNA are suggestive of
DNA gradients within biofilms.
Biofilm formation was inhibited at extracellular DNA concen-
trations $0.5% (w/v) (Fig 6A). This is consistent with the observed
growth inhibition of planktonic cells at similar DNA concentra-
tions (Fig 1A). One-day old PA3553::lux biofilms were washed to
remove non-adhered cells and gene expression was measured from
the cells adhered to the polystyrene peg surface. PA3553 gene
expression was strongly induced, up to 20-fold, in peg-adhered
biofilms, with the highest induction at 0.5% (w/v) extracellular
DNA (Fig 6B). Although gene expression was measured in a
mutant background, both PAO1 and PA3553::lux had similar
biofilm phenotypes in each condition tested (Fig 6A). In biofilms
cultivated in the presence of extracellular DNA supplemented with
excess Mg
2+ (5 mM), PA3553 gene expression was completely
repressed (data not shown).
DNA chelation of Mg
2+,C a
2+ or Mn
2+ but not Zn
2+
induces PA3553 expression
At lethal concentrations, extracellular DNA induced cell lysis by
chelating cations from the OM. This antimicrobial activity can be
prevented if DNA is pre-loaded with Mg
2+,C a
2+ or Mn
2+, but not
Zn
2+, prior to treatment of cells (Fig 3A and 3B). To determine the
specificity of cation chelation, flame atomic absorption spectros-
copy was employed to quantitate DNA-dependent removal of
cations from buffer containing known concentrations of Mg
2+,
Ca
2+,M n
2+ or Zn
2+ and a combination of all four cations. DNA
was capable of binding all four cations at similar levels (80–88%),
whether alone (Fig 7A) or in combination (data not shown). To
ensure binding was specific to DNA a negative control was
included. The concentration of Mg
2+ that bound to the column in
the absence of DNA is indicated.
At sub-lethal concentrations, extracellular DNA imposes a
cation limitation that leads to induction of PA3553 (Fig 4A), which
can be repressed by excess Mg
2+ (Fig 4B), indicating that P.
aeruginosa senses Mg
2+. The P. aeruginosa PhoQ sensor kinase
Figure 3. DNA induces cell death by acting as a cation chelator.
(A) Killing assays indicate relative protection provided by cations
following pre-incubation of salmon sperm DNA with cations (25 mM
Mg
2+; 6.25 mM Ca
2+; 6.25 Mn
2+; 3.125 mM Zn
2+) in Hepes buffer
(50 mM, pH 7.4). (B) Restoration of PAO1 growth in BM2 supplemented
with 1.5% (w/v) DNA following addition of excess individual cations
(10 mM Mg
2+,1 0 m MC a
2+,0 . 5 m MM n
2+,2 . 5 m MZ n
2+). Each
experiment was performed at least five times and representative
curves are shown. Standard deviations for each experiment were not
greater than +/210% of the value shown.
doi:10.1371/journal.ppat.1000213.g003
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2+ and
Ca
2+ cations [63,64]. Under limiting Mg
2+ conditions, the
addition of excess Mg
2+,C a
2+ or Mn
2+, but not Zn
2+, repressed
PA3553 expression (Fig 7B). Taken together, these data indicate
that P. aeruginosa can sense the presence of Mg
2+,C a
2+ or Mn
2+
and that chelation of these same cations by DNA results in
induction of the PA3552–PA3559 LPS modification operon.
DNA induces resistance to CAPs and aminoglycosides
To determine if DNA-induced expression of PA3552–PA3559
resulted in increased resistance to antimicrobials, antibiotic
susceptibility testing of P. aeruginosa biofilms grown in the presence
and absence of extracellular DNA was performed. Biofilms were
cultivated on 96-well format, polystyrene pegs submerged in BM2
defined media, with or without sub-inhibitory concentrations of
extracellular DNA (0.75% (w/v)), and challenged with antibiotics.
After antibiotic challenge, this assay allows for determination of
both the minimum inhibitory concentration (MIC) of planktonic
cultures and the minimum biofilm eradication concentration
(MBEC).
Consistent with previous results reporting on the antibiotic
resistance phenotype of bacterial biofilms [6,19], the MBEC values
of biofilms cultivated in magnesium-replete conditions and treated
with CAPs (polymyxin B, colistin) or aminoglycosides (gentamycin,
tobramycin) were up to 64-fold higher than the MIC values of
planktonic cultures (Table 1). The MBEC values of biofilms
supplemented with extracellular DNA were 8 and 64-fold more
CAP and aminoglycoside resistant than biofilms without exoge-
nous DNA, respectively (Table 1). DNA-enriched biofilms were
dramatically more resistant than planktonic cultures, up to 256-
fold, and this resistance phenotype to CAPs and aminoglycosides
was also observed in planktonic cultures supplemented with DNA.
The simple addition of sub-inhibitory DNA amounts to planktonic
Figure 5. Visualization of DNA as a component of peg-adhered
biofilms. (A) The extracellular stain DDAO demonstrated DNA is a
component of PAO1 biofilms cultivated in BM2 on pegs (406
magnification). (B) PI staining indicates the presence of DNA as a
mesh-like pattern in 1 day-old biofilms (right panel) (406 magnifica-
tion). The scale bar equals 10 microns. Images presented are
representative of triplicate experiments.
doi:10.1371/journal.ppat.1000213.g005
Figure 4. Extracellular DNA induces PA3553 gene expression in
planktonic cultures. Effects of (A) salmon sperm DNA, (B) salmon
sperm DNA in the presence of excess (5 mM) Mg
2+ (C) sonicated P.
aeruginosa PAO1 genomic DNA and (D) DNAsed salmon sperm DNA on
the expression of the PA3553::lux transcriptional fusion in planktonic
cultures. Gene expression was normalized to growth for each condition
and CPS/OD600 values are presented. Each growth experiment was
performed at least five times and representative curves are shown. (D)
Buffer control indicates that this sample was treated identically to the
DNAsed DNA sample except for the addition of DNAseI enzyme.
Standard deviations for each experiment were not greater than +/210%
of the value shown.
doi:10.1371/journal.ppat.1000213.g004
DNA Induces Antibiotic Resistance
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a biofilm (Table 1).
The MIC values for polymyxin B and gentamicin are equal to
1 mg/ml and 2 mg/ml, respectively, using the standard microbroth
dilution method for antimicrobial susceptibility testing (National
Committee on Clinical Laboratory Standards (NCCLS) protocol)
(data not shown). Thus, depending on the method used to
determine the MIC (CBD or NCCLS protocol), DNA-enriched
biofilms can be up to 2560-fold more polymyxin B resistant and up
to 640-fold more aminoglycoside resistant than planktonic
cultures. DNA-enriched biofilms did not show an increased
tolerance to ceftazidime (b-lactam) or ciprofloxacin (fluoroquino-
lone) (data not shown). Since extracellular DNA is a natural matrix
component of PAO1 biofilms (Fig 5A and 5B), DNA-induced
antibiotic resistance is likely to be a phenomenon unique to
biofilms or other DNA rich environments. The presence of DNA
in peg-cultivated biofilms (Fig 5A), grown in the absence of
exogenous DNA, likely contributes to the increased antibiotic
resistance generally observed in biofilms (Table 1).
We have shown previously that the PA3552–PA3559 operon is
required for resistance to cationic antimicrobial peptides in
planktonic cultures grown in limiting magnesium conditions
[47]. To determine if DNA-induced resistance requires these
genes in biofilms, the resistance phenotype of the PA3553::lux
mutant was determined. PA3553::lux had no significant DNA-
induced CAP resistance in biofilm or planktonic cultures,
confirming that these genes are essential for CAP resistance in
the presence of extracellular DNA (Table 1). The PA3553 mutant
also displayed decreased DNA-induced resistance to aminoglyco-
sides compared to PAO1. The differences observed between CAP
and aminoglycoside resistance in PA3553::lux suggests that DNA-
induced resistance to aminoglycosides is not limited to PA3553
induction. The biofilms formed by the PA3553::lux mutant were
unaltered compared to PAO1 biofilms under these conditions,
ensuring that the difference observed was not due to an altered
biofilm phenotype (Fig 6B).
The CAP resistance phenotype of biofilms grown in limiting
magnesium (20 mM) was similar to biofilms grown in DNA,
confirming that DNA imposes a magnesium limitation stress
(Table 2). Biofilms that were exposed to DNA during either the
cultivation or challenge stages only, showed similar resistance
profiles to biofilms grown and challenged in magnesium-replete
Figure 7. Multiple cations are bound by DNA and repress the
induction of PA3553 gene expression. (A) Elemental analysis of
cations in buffer after size-exclusion centrifugation to remove DNA
illustrates percentage bound to DNA. Values presented represent the %
(w/v) bound to DNA relative to the total amount of cation added. The
negative control indicated relates to the concentration of Mg
2+ that
bound to the column in the absence of DNA. (B) The influence of excess
Mg
2+,C a
2+,M n
2+ or Zn
2+ on PA3553 gene expression when grown in
BM2 media with low (20 mM) Mg
2+. Cations are added at concentrations
of 5 mM, 5 mM, 1 mM and 2.5 mM, respectively. A representative curve
from triplicate experiments is shown. Standard deviations for each
experiment were not greater than +/210% of the value shown.
doi:10.1371/journal.ppat.1000213.g007
Figure 6. Extracellular DNA induces PA3553 gene expression in
peg-adhered biofilms. (A) Adhesion of PAO1 and PA3553::lux to
polystyrene pegs assessed by crystal violet staining and OD600
measurement at 24 h in cultures supplemented with salmon sperm
DNA, as indicated. (B) Gene expression from PA3553::lux was monitored
in peg-adhered biofilms at 24 h in DNA supplemented conditions, as
indicated. CPS values were normalized to the number of peg-adherent
cells (OD600 of CV staining). Bars in (A) and (B) represent the average
values obtained from eight pegs and the error bars represent the
standard deviations.
doi:10.1371/journal.ppat.1000213.g006
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biofilms requires both the cultivation and challenge under cation-
limiting conditions. These latter two observations rule out the
possibility that negatively charged DNA simply interacts with
cationic antimicrobial peptides and prevents their access to
bacterial cells.
Discussion
Infections caused by P. aeruginosa continue to be a leading cause
of mortality among immunocompromised patients. The ability of
P. aeruginosa to form biofilms promotes survival of the bacteria in
the presence of antimicrobials and host defense mechanisms and is
thought to contribute significantly to its ability to survive long-term
within the hostile environment of chronically-infected patients.
Understanding the mechanisms underlying antibiotic resistance
and especially biofilm-specific antimicrobial resistance is of
significant importance in the development of new treatment
options and/or strategies.
We have identified a novel mechanism of biofilm-associated
antibiotic resistance in which the presence of DNA in the
extracellular matrix of biofilms creates a localized cation-limited
environment that is detected by P. aeruginosa leading to the
induction of LPS modification genes and resistance to antimicro-
bials. Magnesium limitation has long been known as an in vitro
signal that induces resistance to CAPs in P. aeruginosa [59]. As an
intracellular pathogen, the PhoPQ system of Salmonella typhimurium
is activated by limiting magnesium in vitro and phoP-regulated genes
are also induced after invasion of macrophages and epithelial cells
[65]. These observations suggested that Mg
2+ is limiting within
host cells, but it was recently shown that vacuole acidification and
low pH is the crucial environmental trigger of PhoPQ activation
[66]. Many extracellular pathogens possess homologs of the
cation-sensing PhoPQ TCS that responds to magnesium limitation
and induces genes necessary for surviving this environmental
challenge [65]. However, to date the identification of a relevant in
vivo environment for P. aeruginosa which is cation limited has
remained elusive. We have demonstrated that DNA-rich environ-
ments, such as biofilms, are cation limited.
While Mg
2+ limitation has been identified as a signal involved in
induced resistance to aminoglycosides in P. aeruginosa [59], the
contribution of the PhoPQ-regulated LPS modifications has not
been clearly determined. PhoQ mutants, which constitutively
express phoP and are constitutively resistant to cationic antimicro-
bial peptides, are also more resistant to aminoglycosides [43]. In S.
typhimurium, PhoPQ regulates multiple LPS modifications that
decrease the OM permeability to membrane cationic dyes, bile
salts and antibiotics, including gentamicin [67]. We report here
that DNA-induces aminoglycoside resistance in P. aeruginosa
biofilms, and this resistance is partially dependent on the LPS
modification operon PA3552–PA3559. The aminoarabinose mod-
ification likely blocks the self-promoted uptake of aminoglycosides,
which normally bind and displace cations that crosslink adjacent
LPS molecules [68].
Previous reports have documented the involvement of P.
aeruginosa PmrAB [49] and the E. coli PmrAB homologs BasRS
[69] in regulating the formation of an antimicrobial peptide-
tolerant subpopulation within biofilms. In pure culture P. aeruginosa
biofilms, genomic DNA localizes throughout the biofilm surface
monolayer and surrounds the mushroom-shaped microcolonies
[51]. This coincides with the localization of a CAP-tolerant
subpopulation of bacteria that expresses the PA3552–PA3559
operon along the surface of mushroom-structured P. aeruginosa
biofilms [49]. To date, it was thought unlikely that a biofilm
environment may be cation limited. However, our data indicates
that the presence of DNA in biofilms does indeed result in a
cation-limited environment, resulting in the induction of the LPS
modification operon PA3552–PA3559.
To our knowledge this is the first report to identify the
antimicrobial properties of DNA. Above certain concentrations
Table 1. Influence of extracellular DNA on antibiotic resistance in biofilms.
Strain Cultivation and challenge conditions
a MIC
b MBEC
c
PxnB Coln Gm Tm PxnB Coln Gm Tm
PAO1 2DNA 10 10 5 1.25 640 320 20 5
PAO1 +DNA 1280 320 1280 320 2560 2560 1280 640
PA3553::lux 2DNA 10 10 5 1.25 640 640 10 10
PA3553::lux +DNA 20 20 10 5 320 320 320 160
aBiofilms were cultivated and challenged in BM2 defined medium (2 mM Mg
2+) with or without 0.75% (w/v) salmon sperm DNA, as indicated.
bThe minimum inhibitory concentration (MIC) is defined as the lowest concentration of antibiotic required to inhibit the growth of planktonic cells that were shed from
the peg.
cThe minimum biofilm eradication concentration (MBEC) is defined as the lowest concentration of antibiotic required for complete killing of the surface-adhered biofilm.
The MIC and MBEC values shown are the median values from four replicate experiments.
PxnB=polymyxin B; Coln=colistin; Gm=gentamycin; Tm=tobramycin.
doi:10.1371/journal.ppat.1000213.t001
Table 2. DNA-induced resistance of biofilms requires both
cultivation and challenge under cation-limiting conditions.
Strain Cultivation conditions
a Challenge conditions
a MBEC
b
PxnB Coln
PAO1 2 mM Mg
2+ 2m MM g
2+, 0.75% DNA 640 640
PAO1 20 mMM g
2+ 20 mMM g
2+ 2560 2560
PAO1 2 mM Mg
2+, 0.75% DNA 2 mM Mg
2+ 640 320
aBiofilms were cultivated and challenged in BM2 defined medium containing
different Mg
2+ concentrations with or without DNA, as indicated.
bThe minimum biofilm eradication concentration (MBEC) is defined as the
lowest concentration of antibiotic required for complete killing of the surface-
adhered biofilm. The MBEC values shown are the median values from four
replicate experiments.
The minimum inhibitory concentration (MIC) is defined as the lowest
concentration of antibiotic required to inhibit the growth of planktonic cells
that were shed from the peg.
PxnB = polymyxin B; Coln = colistin.
doi:10.1371/journal.ppat.1000213.t002
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biofilm formation. Recently, a novel host defense mechanism was
discovered whereby stimulated neutrophils ejected a mesh-like net
of intracellular DNA and proteins that functions to trap and kill
pathogens [70]. The antimicrobial property of neutrophil nets was
attributed to DNA-associated histones and other antimicrobial
peptides [70]. However, our results demonstrate that above certain
concentrations, the DNA itself is antimicrobial due to cation
chelation. In principle, cation chelation by DNA is similar to
another recently identified host defense mechanism, where the
Mn
2+ and Zn
2+ metal chelation properties of the host innate-
immune protein calprotectin was shown to limit Staphylococcus
aureus growth in tissue abscesses [71].
Staining of peg-adhered biofilms indicated that DNA was
present throughout the biofilm. (Fig 5B). This data supports the
hypothesis that the release of genomic DNA by lysed cells
following exposure to inhibitory concentrations of extracellular
DNA may result in a continual release of DNA by dying cells and
a DNA gradient within the biofilm. Our observation that DNA
imposes a cation gradient in biofilm is also consistent with previous
reports of oxygen and nutrient gradients within biofilms, which
result in diverse physiological cellular states within a biofilm
community [72].
Although DNA is toxic at high concentrations, it functions as
a double-edged sword whereby sub-inhibitory DNA concentra-
tions serve to protect bacteria from antibiotic exposure, either
from the host immune response or from antimicrobial
treatment. It has previously been reported that Mg
2+ concen-
trations within the airway surface fluid are high (2.2 mM)
[73,74]. However, sputum samples from the lungs of CF
patients have very high concentrations of DNA, up to 20 mg/
ml (2% (w/v)) [75,76]. It is likely that within the CF lung,
localized cation limited environments exist within DNA-rich
microcolonies. It is also known that CF airway fluid contains
high levels of neutrophil defensins [77] and that sub-lethal doses
of CAPs induce PA3553 gene expression, although indepen-
dently of PhoPQ and PmrAB [45]. Therefore, it appears that
there are multiple environmental signals in the CF lung that
can induce the expression the PA3552–PA3559 operon, which
may explain why many P. aeruginosa CF isolates show LPS
modifications such as aminoarabinose addition to lipid A [78].
As many P. aeruginosa strains isolated from the CF lung
overproduce the negatively charged EPS alginate, we hypoth-
esized that alginate may also be a relevant in vivo signal
inducing expression of the PA3552–PA3559 operon. However,
induction of PA3553 gene expression does not occur in the
presence of alginate (data not shown).
The observation that DNA is present in the lungs of CF
patients has prompted the use of DNAseI as a therapeutic agent
to reduce the sputum viscosity and improve lung function
[75,76]. However, our data suggests that the success of DNAseI
therapy may, in part, be attributed to the degradation of DNA
and subsequent disarming of the PhoPQ/PmrAB response and
antibiotic resistance mechanisms. While previous studies have
shown the biofilm matrix to function as a diffusion barrier to
antibiotics, these results demonstrate a novel function of the
biofilm matrix component DNA, where the cation chelating
properties of DNA in biofilms induces resistance to host-derived
or therapeutic antimicrobials. Furthermore, these findings
indicate that DNA-rich environments, such as bacterial biofilms
or the CF lung, may represent the natural setting where bacterial
growth is cation limited, and highlight the importance of the
PhoPQ/PmrAB controlled response and LPS modifications in
antibiotic resistance in biofilms.
Materials and Methods
Bacterial strains
Pseudomonas aeruginosa PAO1 and lux-tagged PAO1::p16Slux [79]
were used as wild-type strains. The mini-Tn5-lux transposon
mutant in the CAP resistance gene PA3553::lux (arnC) was
previously constructed [47]. For all experiments involving DNA,
DNA was isolated in the absence of EDTA and resuspended in the
buffer or media in which each experiment was carried out.
Growth inhibition, growth restoration and killing assays
Growth kinetics of P. aeruginosa was carried out in LB or BM2
media [47] supplemented with low molecular weight salmon
sperm (Fluka) or P. aeruginosa genomic DNA, with and without the
addition of various cations in excess (25, 12.5, 6.25, and
3.125 mM). Cation sources were MgCl2, CaCl2, MnCl2 and
ZnCl2. For Mg
2+ supplementation, no difference was observed
when MgCl2 was substituted with MgSO4. Growth assays were
carried out in 100 ml volumes in transparent 96-well plates (Nunc).
Fifty ml of sterile mineral oil was added to each well to prevent
evaporation during the assay. Microplate planktonic cultures were
incubated at 37uC in a Wallac Victor
3 luminescence plate reader
(Perkin-Elmer) and optical density (growth, OD600) readings were
taken every 20 minutes throughout growth. Killing assays were
carried out as previously described [80]. Briefly, overnight cultures
of PAO1::p16Slux were washed and diluted in 25 mM sodium
phosphate or 50 mM Hepes buffer, pH 7.4, as indicated in the
figure legends. 5610
7 cfu were exposed to varying concentrations
of salmon sperm DNA, in the presence or absence of excess
cations, and CPS monitored over time, as a measure of viability.
Each growth or killing experiment was performed at least five
times and representative curves are shown.
Cultivation and imaging of peg adhered biofilms
For microscopy analysis of peg-adhered biofilms, PAO1 was
cultivated on pegs (NUNC-TSP), washed as described below and
stained with 1 mM 7-hydroxy-9H-(1,3-dichloro-9,9-dimethylacri-
din-2-one) (DDAO) (Molecular Probes) or 10 mM propidium
iodide (PI) for 10 mins. Individual pegs were removed and placed
on a drop of 0.9% saline on a glass slide prior to visualization.
Images were captured with a Leica DMIREB2 inverted,
epifluorescence microscope.
DNA lysis, live cell imaging and P. aeruginosa specific
semi-quantitative PCR
For DNA lysis experiments, overnight cultures of PAO1
producing mCherry fluorescent lipoproteins with sorting signals
for either the OM (lipoCSFP-ChFP) or IM (lipoCKVE-ChFP) were
subcultured 1/100 and grown for 3 h to mid-log phase (OD 0.5)
[60,61].Overnight cultureswerediluted 1 in100andgrowntomid-
log phase. 1.5610
8 cells were spun, washed in sodium phosphate
buffer (25 mM, pH 7.4) and resuspended in 50 ml of 1 mM EDTA,
2% (w/v) salmon sperm DNA or buffer alone (negative control).
Cells were lysed for 10 mins, pelleted (8000 rpm, 5 mins) and 1 ml
of supernatent used as a template for semi-quantitative PCR (25
cycles). PCR was carried out on lysates obtained from 2% (w/v)
DNA, 1 mM EDTA and untreated control cells. For P. aeruginosa
specific PCR studies, 1 ml of the lysate was used as a template for
semi-quantitative PCR using P. aeruginosa specific primers (F-59
gaggatcccgccgggttttttgtgtctg-39, R-59gaggatcccaggagtgatattagc-
gattc-39). These primers amplify a 216 bp product corresponding
to the promoter region of the rsmZ gene in P. aeruginosa. PCR
controls included 2% (w/v) salmon sperm DNA alone to ensure the
specificity of the primers for P. aeruginosa DNA, a negative PCR
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aeruginosa genomic DNA as template.
For microscopy, cells were washed, concentrated 2.5 fold in
sodium phosphate buffer (25 mM, pH 7.4) and stained with
10 mM PI or left unstained. Cells were visualized on agarose beds
with a Leica DMIREB2 inverted microscope equipped with an
ORCA-ER digital camera and Openlab software (Improvision).
For DNAse treatment of DNA/EDTA lysed cells or relevant
controls, cells were treated with DNAseI (500 mg/ml) for 45 mins
at 37uC prior to the addition of fluorescent dyes and microscopic
analysis.
Measurement of chelating ability of DNA
To determine the specificity of cation chelation by DNA, 1.25%
(w/v) salmon sperm DNA was resuspended in 50 mM Hepes
buffer, pH 7.4, and incubated individually with 2.5 mM Mg
2+,
Ca
2+,Z n
2+ or Mn
2+ or a cocktail of 0.625 mM of each cation.
After 3 h incubation at room temperature with constant rotation,
samples were centrifuged in a Amicon ultra column (Millipore)
with a 10 kDa cutoff (3200 g for 30 mins). All unbound cations
passed through the filter but DNA was retained. The filtrate was
sent for flame atomic absorption spectroscopy analysis to
determine the percentage of cation not bound by DNA (Bodycote
Testing Group, Portland, OR, USA). Values represented are the
percent of cations bound to DNA.
Real-time gene expression in planktonic and biofilm
cultures
Overnight cultures were grown in LB medium or BM2 defined
medium (20 mM succinate) supplemented with 2, 1 or 0.02 mM
Mg
2+ and extracellular DNA as indicated, diluted 1/100 into
100 ml of culture medium in 96-well black plates with a
transparent bottom (9520 Costar; Corning Inc.) and overlayed
with 50 ml of mineral oil to prevent evaporation. Microplate
planktonic cultures were incubated at 37uC in a Wallac Victor
3
luminescence plate reader (Perkin-Elmer) and optical density
(growth, OD600) and luminescence (gene expression, CPS)
readings were taken every 20 minutes throughout growth. For
DNAse treatment experiments, 2% salmon sperm DNA was
treated for 48 hrs at 37uC with 500 mg/ml of DNAseI enzyme in
40 mM Tris, 10 mM MgSO4 and CaCl2. Biofilms were cultivated
on 96-well format, polystyrene pegs (Nunc-TSP) that were
immersed in 200 ml of growth medium. After biofilm cultivation,
non-adherent cells were removed by rinsing the pegs in 0.9%
NaCl. Gene expression in peg-adhered biofilms was measured by
luminescence readings in the Wallac MicroBeta Trilux multi-
detector (Perkin-Elmer). Biofilm formation on the pegs was
quantitated by crystal violet (CV) staining (OD600) as previously
described [81].
Antimicrobial susceptibility testing in biofilms
P. aeruginosa biofilms were tested for susceptibility using the
Calgary Biofilm Device protocol [6]. Overnight cultures of P.
aeruginosa PAO1 and PA3553::lux were grown in BM2 defined
medium with magnesium concentrations as indicated and
supplemented with 0.75% (w/v) salmon sperm DNA. This
concentration of DNA was not toxic in BM2 medium with
2m M M g
2+. Starter cultures were diluted in the appropriate
medium and inoculated at a concentration of 1.5610
6 cfu/well.
Biofilms were cultivated on the peg lids by shaking the plate at
37uC for 24 hours. The pegs were rinsed twice in 0.9% NaCl and
transferred to challenge plates, which consisted of a serial two-fold
dilution gradient of polymyxin B, colistin, gentamycin or
tobramycin. Peg-adhered biofilms were challenged in the same
media in which they were cultivated. Following a 24-hour
antibiotic challenge, the MIC values were determined by
measuring growth (OD600) in the challenge plate. After biofilm
challenge, the surviving cells in peg-adhered biofilms were rinsed
twice in 0.9% NaCl, DNAseI treated (25 mg/ml) for 30 mins and
sonicated for 10 mins to remove attached cells. The surviving cells
were enumerated by serial dilution and plate counts to determine
the MBEC value.
Supporting Information
Figure S1 DNA released from lysed cells forms a mesh-like
coating surrounding and connecting individual cells. Propidium
iodide (PI) staining of DNA or EDTA lysed cells and relevant
controls in the absence and presence of DNAse treatment.
Found at: doi:10.1371/journal.ppat.1000213.s001 (10.27 MB
TIF)
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